HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xudong Wang Selected Research

WP1066

1/2018STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
12/2014WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
5/2014STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
5/2014[Signal transducer and activator of transcription-3 inhibitor WP1066 affects human tongue squamous cell carcinoma proliferation and apoptosis in vitro and in vivo].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xudong Wang Research Topics

Disease

114Neoplasms (Cancer)
05/2022 - 12/2010
32Neoplasm Metastasis (Metastasis)
12/2021 - 06/2012
22Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2013
17Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2013
12Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2013
12Lymphatic Metastasis
11/2021 - 12/2012
12Carcinogenesis
01/2021 - 12/2010
11Multiple Myeloma
01/2020 - 03/2009
11Breast Neoplasms (Breast Cancer)
08/2019 - 04/2011
9Inflammation (Inflammations)
05/2022 - 04/2016
8Infections
02/2022 - 09/2010
6Carcinoma (Carcinomatosis)
07/2021 - 03/2014
6Obesity
01/2021 - 03/2002
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 01/2015
6Hepatocellular Carcinoma (Hepatoma)
07/2018 - 02/2012
5Osteosarcoma (Osteogenic Sarcoma)
10/2022 - 01/2016
5Wounds and Injuries (Trauma)
01/2022 - 11/2013
5Adenocarcinoma of Lung
01/2022 - 11/2015
5Osteoporosis
10/2021 - 01/2019
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 07/2016
5Acute Kidney Injury (Acute Renal Failure)
06/2020 - 11/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 01/2012
4Lung Neoplasms (Lung Cancer)
10/2021 - 12/2012
4Osteoarthritis
01/2021 - 01/2019
4Malocclusion (Crossbite)
12/2020 - 05/2014
4Osteochondroma (Osteocartilaginous Exostosis)
07/2020 - 11/2013
4Colonic Neoplasms (Colon Cancer)
01/2019 - 05/2010
4Necrosis
01/2018 - 01/2005
4Hypoxia (Hypoxemia)
09/2015 - 03/2002
3Insulin Resistance
07/2021 - 01/2014
3Non-alcoholic Fatty Liver Disease
07/2021 - 01/2020
3Fibrosis (Cirrhosis)
05/2021 - 07/2018
3Adenocarcinoma
01/2021 - 01/2016
3Hyperglycemia
01/2020 - 08/2005
3Thyroid Neoplasms (Thyroid Cancer)
11/2018 - 09/2016
3Pain (Aches)
01/2018 - 03/2015
3Melanoma (Melanoma, Malignant)
07/2016 - 12/2012
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2010 - 11/2006
2Congenital Abnormalities (Deformity)
12/2022 - 01/2022
2Atherosclerosis
05/2022 - 01/2022
2Stroke (Strokes)
05/2022 - 10/2020
2Sepsis (Septicemia)
01/2022 - 01/2022
2Papillary Thyroid Cancer
12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2010
28Biomarkers (Surrogate Marker)IBA
04/2022 - 06/2012
16Biological ProductsIBA
01/2022 - 03/2002
13MicroRNAs (MicroRNA)IBA
01/2020 - 05/2014
12Messenger RNA (mRNA)IBA
05/2020 - 12/2012
12Long Noncoding RNAIBA
01/2020 - 10/2014
9Pharmaceutical PreparationsIBA
01/2022 - 09/2011
8Indicators and Reagents (Reagents)IBA
10/2021 - 01/2012
7EnzymesIBA
02/2022 - 12/2010
7MelatoninIBA
01/2022 - 01/2019
6Therapeutic UsesIBA
12/2022 - 12/2014
6CytokinesIBA
05/2022 - 01/2005
6LigandsIBA
01/2021 - 01/2013
6Insulin (Novolin)FDA Link
01/2018 - 03/2002
5CateninsIBA
04/2022 - 01/2017
5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 07/2008
5Cisplatin (Platino)FDA LinkGeneric
07/2021 - 12/2014
4LuciferasesIBA
07/2021 - 05/2014
4Hormones (Hormone)IBA
01/2021 - 01/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2015
4AntigensIBA
09/2020 - 05/2014
4Cystatin CIBA
02/2020 - 11/2014
4WP1066IBA
01/2018 - 05/2014
4Cadherins (E-Cadherin)IBA
04/2015 - 01/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2005
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2019
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
3Circular RNAIBA
12/2021 - 01/2021
3baicaleinIBA
07/2021 - 04/2015
3Deubiquitinating EnzymesIBA
07/2021 - 01/2021
3IntegrinsIBA
12/2020 - 09/2011
3AntioxidantsIBA
06/2020 - 01/2019
3CreatinineIBA
02/2020 - 11/2014
3Cetuximab (Erbitux)FDA Link
01/2020 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2015
3Superoxide Dismutase-1IBA
12/2019 - 01/2019
3Estrogen ReceptorsIBA
01/2019 - 03/2014
3Untranslated RNA (Noncoding RNA)IBA
01/2019 - 10/2014
3ChromatinIBA
11/2018 - 10/2014
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2018 - 05/2014
3Antisense RNA (Anti-Sense RNA)IBA
01/2018 - 10/2014
3Small Interfering RNA (siRNA)IBA
09/2016 - 05/2010
3B-Cell Activating FactorIBA
04/2016 - 03/2009
2HydrogelsIBA
12/2022 - 01/2022
2N-methyladenosineIBA
01/2022 - 01/2021

Therapy/Procedure

34Therapeutics
05/2022 - 08/2005
12Drug Therapy (Chemotherapy)
05/2022 - 05/2010
8Orthognathic Surgery
01/2022 - 07/2014
6Distraction Osteogenesis
10/2022 - 04/2009
6Radiotherapy
01/2021 - 05/2011
6Osteotomy
12/2015 - 09/2012
4Aftercare (After-Treatment)
01/2022 - 12/2007
3Genioplasty
10/2022 - 11/2014
3Gastrectomy
07/2019 - 06/2018
3Endoscopes
03/2015 - 11/2013
2Debridement
01/2022 - 09/2010
2Adjuvant Chemotherapy
01/2022 - 01/2021